MUSC Hollings Cancer Center

Name

MUSC Hollings Cancer Center

Legal name

Medical University of South Carolina Hollings Cancer Center

Website

https://hollingscancercenter.musc.edu

Company type

Private

Founded year

1824

Operating status

Operating

Headcount range

5,001–10,000 employees

Ownership category

akta.pro rank

Product category

Cancer Treatment and Research Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Specialty (except Psychiatric and Substance Abuse) Hospitals (62231), Diagnostic Imaging Centers (621512)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Surgical Oncology (HLAKAFAG), Gynecologic Oncology (HLAKAFAF)

Keywords

• Cancer treatment services
• Oncology research
• Cancer screening programs
• Hereditary cancer counseling
• Clinical trials oncology

Headquarters

HQ city

Charleston

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Patient Care Services: Clinical care reimbursement through health insurance, Medicare, Medicaid for cancer treatment, screening, and related healthcare services. This is the primary revenue source for the cancer center.
2. Research Grants and Funding: Grant funding from National Cancer Institute (P30CA138313), American Cancer Society, and other research organizations supporting clinical trials, survivorship research, and cancer prevention studies.
3. Donations and Philanthropy: Philanthropic donations through fundraise.musc.edu supporting cancer research, patient care, and community programs. Major gift programs and event-based fundraising.

Go-to-market motion3 records

Distribution channels6 records

Marketing channels8 records

Core offering

MUSC Hollings Cancer Center is South Carolina's only National Cancer Institute (NCI)-designated cancer center, delivering comprehensive oncology patient care (surgery, chemotherapy, radiation, immunotherapy, targeted therapy), advanced screening and genetic counseling, clinical trials, cancer research, and statewide community outreach programs. It operates as part of the Medical University of South Carolina and offers specialized programs such as the Hereditary Cancer Clinic, High-Risk Breast Evaluation Program, and Tobacco Treatment Program alongside AI-driven tools like Ask2Me.org and a Financial Toxicity Risk Calculator.

Product overview

MUSC Hollings Cancer Center is South Carolina's only National Cancer Institute-designated cancer center, offering a comprehensive portfolio of cancer care, research, education, and community outreach services. The center provides patient care through multiple specialized programs including the Hereditary Cancer Clinic (offering genetic counseling, testing, and the Ask2Me.org AI platform), High-Risk Breast Evaluation Program, and Tobacco Treatment Program. Advanced diagnostic technologies include liquid biopsy/ circulating DNA testing and comprehensive imaging services (3D mammography, MRI, ultrasound). Research programs span cancer biology, prevention, therapeutics, and survivorship (SCOR Initiative). Community outreach includes mobile health units, HPV vaccination programs, and initiatives like SC AMEN for prostate cancer education. The center also offers AI-powered tools including a financial toxicity risk calculator and cancer genetics knowledge platforms.

Differentiator

Problem solved

Functional benefit

Products and services

• Hereditary Cancer Clinic
• High-Risk Breast Evaluation Program
• Liquid Biopsy (Circulating DNA Testing)
• Ask2Me.org
• SC AMEN Program
• Tobacco Treatment Program
• Survivorship and Cancer Outcomes Research (SCOR) Initiative
• Mobile Health Unit
• HPV Mobile Vaccination Unit
• Financial Toxicity Risk Calculator
• Genetic Counseling Services
• Hereditary Diffuse Gastric Cancer Clinic

Quantifiable outcome

• 50% reduction in invasive melanoma risk with regular sunscreen use
• +5 more outcomes

Named customers8 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability10 records

Feature5 records

Partnerships

Eight partnerships are on record, tiered minor and core.

• Hope Lodge CharlestonminorStrategic or Co-development PartnerPartnership with Hope Lodge Charleston to offer monthly educational and support meetings for head and neck cancer patients, caregivers, and those affected by head and neck cancer. Sessions offered in hybrid format.
• Blood Cancer UnitedminorStrategic or Co-development PartnerFormerly Leukemia & Lymphoma Society, Blood Cancer United supports the South Carolina Virtual Blood Cancer Support Group facilitated by MUSC Hollings Cancer Center social workers. Meets third Thursday monthly.
• Hollings Cancer Network (Partner Hospitals)coreChannel Partner/ Reseller/ DistributorStatewide network of partner hospitals including Tidelands Health, Florence Medical Center, and other regional facilities extending NCI-designated cancer care to communities across South Carolina.
• Tidelands HealthcoreChannel Partner/ Reseller/ DistributorHollings Cancer Network partner providing chemotherapy and cancer care closer to home for patients in the region, with oncologists working closely with Hollings subspecialists.
• MD Anderson Cancer CenterminorStrategic or Co-development PartnerCollaboration on cervical cancer elimination research paper. Researchers from MUSC Hollings Cancer Center worked with colleagues at MD Anderson Cancer Center to quantify state-by-state progress toward cervical cancer elimination.
• University of Puerto Rico Comprehensive Cancer CenterminorStrategic or Co-development PartnerCollaboration on cervical cancer elimination research quantifying progress toward elimination goals across U.S. states and territories.
• HPV Vaccination Roundtable of the SoutheastminorStrategic or Co-development PartnerTrisha Amboree, Ph.D. actively involved with this coalition which has developed toolkits for public health leaders to improve HPV vaccination and cervical cancer prevention across the Southeast region.
• Community Organizations (SC AMEN, SC CHEER YES, SC SPOT, SC CADRE, SC CHEC)coreStrategic or Co-development PartnerCommunity outreach partnerships addressing cancer disparities, education, and screening access across South Carolina's diverse populations.

Scale indicators12 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• UNC Lineberger Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center at the University of North Carolina. Closely comparable as a public academic cancer center serving an adjacent Southeastern state, with overlapping population-health, HPV vaccination, and rural outreach priorities.
• Duke Cancer Institute: NCI-designated cancer center at Duke University combining research, clinical care, and education. Comparable in operating model, NCI designation, and regional academic positioning, and located within driving distance of large portions of South Carolina, making it a direct competitive peer for complex oncology referrals.
• Memorial Sloan Kettering Cancer Center: NCI-designated Comprehensive Cancer Center providing multidisciplinary oncology care, translational research, and clinical trials. Closely matches Hollings' specialty-hospital-plus-research-platform model, with a similarly broad cancer-type portfolio and emphasis on hereditary cancer and survivorship.
• Winship Cancer Institute of Emory University: NCI-designated Comprehensive Cancer Center in the Southeast with multidisciplinary care, research, and community outreach programs. Highly comparable model — public academic, NCI designation, regional cancer-network strategy — competing with Hollings for Southeastern patient referrals.
• MD Anderson Cancer Center: NCI-designated Comprehensive Cancer Center and one of the largest oncology care and research institutions in the U.S. Directly comparable to MUSC Hollings in operating model — combining clinical care, research, education, and community outreach — but at substantially larger scale. Hollings has an active research collaboration with MD Anderson on cervical cancer elimination.
• Vanderbilt-Ingram Cancer Center: NCI-designated Comprehensive Cancer Center combining research, clinical trials, and specialty oncology care at a major academic medical center. Comparable as a Southeastern public academic cancer center pursuing precision oncology and hereditary cancer programs similar to Hollings.

Broad incumbents

• City of Hope: NCI-designated Comprehensive Cancer Center with a national network strategy, expanding into multiple community sites. Comparable in its model of combining a flagship specialty cancer hospital with affiliated regional locations — directly relevant to Hollings' own hospital-plus-network build-out.
• Atrium Health Levine Cancer Institute: Large multi-state, multi-hospital cancer program based in Charlotte, NC. Comparable as a regional cancer-care network with community-hospital reach into South Carolina; broader, non-academic system but offers overlapping medical oncology and infusion services that compete directly with Hollings' network strategy.
• Mayo Clinic Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center integrated within Mayo Clinic's broader health system. Comparable in clinical-research integration and specialty depth but operates at significantly larger national scale and competes for complex oncology referrals across the Southeast.

Regional players

• Hollings (MUSC) Cancer Network peer hospitals — Tidelands Health: Regional health system along the South Carolina coast serving as a Hollings Cancer Network partner delivering community oncology services. Relevant comparable as the type of community-hospital oncology program that Hollings extends NCI-level care into through its statewide network model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MUSC Hollings Cancer Center